Research Topics

EPAR RESEARCH BRIEF #386
Publication Date: 05/08/2019
Type: Research Brief
Abstract

In many countries in Sub-Saharan Africa and South Asia smallholder farmers are among the most vulnerable to climatic changes, and the observed shocks and stresses associated with these changes impact agricultural systems in many ways. This research brief offers findings on observed or measured changes in precipitation, temperature or both, on five biophysical pathways and systems including variable or changing growing seasons, extreme events, biotic stressors, plant species density, richness and range, impacts to streamflow, and impacts on crop yield. These findings are the result of a review of relevant documents cited in Kilroy (2015), references included in the IPCC draft Special Report on Food Security, and targeted searches from 2015 - present for South Asia and Sub-Saharan Africa. 

EPAR TECHNICAL REPORT #362
Publication Date: 01/16/2019
Type: Data Analysis
Abstract

Self-Help Groups (SHGs) in Sub-Saharan Africa can be defined as mutual assistance organizations through which individuals undertake collective action in order to improve their own lives. “Collective action” implies that individuals share their time, labor, money, or other assets with the group. In a recent EPAR data analysis, we use three nationally-representative survey tools to examine various indicators related to the coverage and prevalence of Self-Help Group usage across six Sub-Saharan African countries. EPAR has developed Stata .do files for the construction of a set of self-help group indicators using data from the Living Standards Measurement Study - Integrated Surveys on Agriculture (LSMS-ISA), Financial Inclusion Index (FII), and FinScope.

We compiled a set of summary statistics for the final indicators using data from the following survey instruments:

  • Ethiopia:
    • Ethiopia Socioeconomic Survey (ESS), Wave 3 (2015-16)
  • Kenya:
    • Kenya FinScope, Wave 4 (2015)
    • Kenya FII, Wave 4 (2016)
  • Nigeria
    • Nigeria FII, Wave 4 (2016)
  • Rwanda:
    • Rwanda FII, Wave 4 (2016)
  • Tanzania:
    • Tanzania National Panel Survey (TNPS), Wave 4 (2014-15)
    • Tanzania FinScope, Wave 4 (2017)
    • Tanzania FII, Wave 4 (2016)
  • Uganda:
    • Uganda FinScope, Wave 3 (2013)
    • Uganda FII, Wave 4 (2016)

The raw survey data files are available for download free of charge from the World Bank LSMS-ISA website, the Financial Sector Deepening Trust website, and the Financial Inclusion Insights website. The .do files process the data and create final data sets at the household (LSMS-ISA) and individual (FII, FinScope) levels with labeled variables, which can be used to estimate summary statistics for the indicators.

All the instruments include nationally-representative samples. All estimates from the LSMS-ISA are household-level cluster-weighted means, while all estimates from FII and FinScope are calculated as individual-level weighted means. The proportions in the Indicators Spreadsheet are therefore estimates of the true proportion of individuals/households in the national population during the year of the survey. EPAR also created a Tableau visualization of these summary statistics, which can be found here.

We have also prepared a document outlining the construction decisions for each indicator across survey instruments and countries. We attempted to follow the same construction approach across instruments, and note any situations where differences in the instruments made this impossible.

The spreadsheet includes estimates of the following indicators created in our code files:

Sub-Populations

  • Proportion of individuals who have access to a mobile phone
  • Proportion of individuals who have official identification
  • Proportion of individuals who are female
  • Proportion of individuals who use mobile money
  • Proportion of individuals who have a bank account
  • Proportion of individuals who live in a rural area
  • Individual Poverty Status
    • Two Lowest PPI Quintiles
    • Middle PPI Quintile
    • Two Highest PPI Quintiles

Coverage & Prevalence

  • Proportion of individuals who have interacted with a SHG
  • Proportion of individuals who have used an SHG for financial services
  • Proportion of individuals who depend most on SHGs for financial advice
  • Proportion of individuals who have received financial advice from a SHG
  • Proportion of households that have interacted with a SHG
  • Proportion of households in communities with at least one SHG
  • Proportion of households in communities with access to multiple farmer cooperative groups
  • Proportion of households who have used an SHG for financial services

Characteristics
In addition, we produced estimates for 29 indicators related to characteristics of SHG use including indicators related to frequency of SHG use, characteristics of SHG groups, and individual/household trust of SHGs.

EPAR Technical Report #345
Publication Date: 12/01/2017
Type: Literature Review
Abstract

The share of private sector funding, relative to public sector funding, for drug, vaccine, and diagnostic research & development (R&D) differs considerably across diseases. Private sector investment in overall health R&D exceeds $150 billion annually, but is largely concentrated on non-communicable chronic diseases with only an estimated $5.9 billion focused on "global health", targeting diseases that primarily affect low and middle-income countries (LMICs). We examine the evidence for five specific disincentives to private sector global health R&D investment: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed and sunk costs, and downstream rents from imperfect markets. Though all five may affect estimates of net returns from an investment decision, they are worth examining separately as each calls for a different intervention or remediation to change behavior.

EPAR Technical Report #339
Publication Date: 09/28/2017
Type: Data Analysis
Abstract

An ongoing stream of EPAR research considers how public good characteristics of different types of research and development (R&D) and the motivations of different providers of R&D funding affect the relative advantages of alternative funding sources. For this project, we seek to summarize the key public good characteristics of R&D investment for agriculture in general and for different subsets of crops, and hypothesize how these characteristics might be expected to affect public, private, or philanthropic funders’ investment decisions. 

Code
EPAR Technical Report #341
Publication Date: 08/03/2017
Type:
Abstract
Data on public expenditures on agriculture are not systematically collected in any one database. Rather, a variety of sources collect and publish data on certain aspects of agricultural public expenditures. These sources vary in their data collection methods, their frequency of data collection, and the specific expenditures they report on. We collected data on agricultural public expenditures and conducted preliminary analyses for four countries: India (with a focus on Bihar, Odisha, and Uttar Pradesh), Ethiopia, Nigeria, and Tanzania. The data are disaggregated in a variety of ways depending on the source, but we include disaggregated data where available comparing planned or budgeted vs. actual spending, government vs. donor spending, soending by activity or funding area, and spending by commodity or value chain activity. Our goals are to facilitate further analysis of trends in agricultural public expenditures across countries and over time, and to highlight gaps and differences in data sources.
EPAR Technical Report #338
Publication Date: 05/19/2017
Type: Literature Review
Abstract

The concept of global public goods represents a framework for organizing and financing international cooperation in global health research and development (R&D). Advances in scientific and clinical knowledge produced by biomedical R&D can be considered public goods insofar as they can be used repeatedly (non-rival consumption) and it is difficult or costly to exclude non-payers from gaining access (non-excludable). This paper considers the public good characteristics of biomedical R&D in global health and describes the theoretical and observed factors in the allocation R&D funding by public, private, and philanthropic sources.